COST-MINIMIZATION ANALYSIS OF USING SHORT AND LONG-ACTING ERYTHROPOESIS-STIMULATING AGENTS FOR CORRECTION OF NEPHROGENIC ANEMIA AGAINST THE BACKGROUND OF SUBSTITUTION THERAPY

• Main Authors: I. S. Krysanov (Author), E. Yu. Ermakova (Author), L. B. Vaskova (Author), M. V. Tiapkina (Author)
• Format: Knjiga
• Izdano: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2021-10-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Clinical trials conducted in various countries indicate that the use of epoetin alfa in patients with nephrogenic anemia in chronic kidney disease can increase the effectiveness of treatment, reduce the incidence of cardiovascular and infectious complications, and reduce mortality in patients with c...